Source link : https://newshealth.biz/health-news/fda-oks-first-non-antipsychotic-for-alzheimers-agitation/

The FDA has approved Auvelity for AD agitation. The combination of dextromethorphan and bupropion is the first oral non-antipsychotic approved for this indication. Medscape Medical News Source link : https://www.medscape.com/viewarticle/fda-oks-first-non-antipsychotic-alzheimers-agitation-2026a1000dze?src=rss Author : Publish date : 2026-05-01 09:46:00 Copyright for syndicated content belongs to the linked Source.

The post FDA OKs First Non-Antipsychotic for Alzheimer’s Agitation first appeared on News Health.

—-

Author : News Health

Publish date : 2026-05-01 09:46:00

Copyright for syndicated content belongs to the linked Source.

—-

12345678

Exit mobile version